0001179110-16-019778.txt : 20160222 0001179110-16-019778.hdr.sgml : 20160222 20160222170606 ACCESSION NUMBER: 0001179110-16-019778 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160218 FILED AS OF DATE: 20160222 DATE AS OF CHANGE: 20160222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHASE WILLIAM J CENTRAL INDEX KEY: 0001563572 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 161445791 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2016-02-18 0 0001551152 AbbVie Inc. ABBV 0001563572 CHASE WILLIAM J 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 EVP, Chief Financial Officer Option (right to buy) 54.86 2016-02-18 4 A 0 95400 0 A 2017-02-18 2026-02-17 Common stock 95400 95400 D Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 31,800 on 02/18/2017, 31,800 on 02/18/2018, and 31,800 on 02/18/2019. Steven L. Scrogham, attorney-in-fact for William J. Chase 2016-02-22